Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,959 | 738 | 99.6% |
| Education | $39.88 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,612 | 165 | $0 (2024) |
| Lilly USA, LLC | $984.05 | 75 | $0 (2024) |
| ABBVIE INC. | $794.25 | 66 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $780.88 | 38 | $0 (2024) |
| Amgen Inc. | $681.95 | 49 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $511.08 | 38 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $459.10 | 31 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $411.41 | 21 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $348.69 | 30 | $0 (2024) |
| Allergan, Inc. | $285.97 | 33 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,846 | 120 | ABBVIE INC. ($319.50) |
| 2023 | $1,283 | 83 | Novo Nordisk Inc ($223.75) |
| 2022 | $1,096 | 79 | ABBVIE INC. ($218.71) |
| 2021 | $599.94 | 40 | PFIZER INC. ($73.03) |
| 2020 | $1,239 | 104 | Novo Nordisk Inc ($203.85) |
| 2019 | $1,443 | 108 | Novo Nordisk Inc ($225.80) |
| 2018 | $1,337 | 106 | Novo Nordisk Inc ($223.60) |
| 2017 | $1,153 | 102 | Novo Nordisk Inc ($203.80) |
All Payment Transactions
742 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Biological | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: UROLOGY | ||||||
| 11/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.82 | General |
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Obesity | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Biological | ||||||
| 10/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: DIABETES | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Obesity | ||||||
| 10/23/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $5.52 | General |
| 10/22/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $3.23 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: UROLOGY | ||||||
| 10/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,679 | 2,690 | $278,990 | $195,076 |
| 2022 | 18 | 1,728 | 2,766 | $290,513 | $201,499 |
| 2021 | 15 | 1,830 | 2,673 | $278,941 | $203,142 |
| 2020 | 15 | 1,919 | 2,603 | $225,795 | $158,090 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 480 | 1,305 | $162,850 | $99,964 | 61.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 409 | 409 | $51,125 | $48,839 | 95.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 229 | $20,610 | $13,047 | 63.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 44 | 48 | $10,080 | $7,196 | 71.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 30 | 32 | $8,800 | $6,242 | 70.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 40 | 40 | $6,400 | $6,144 | 96.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 22 | 22 | $3,740 | $3,373 | 90.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 111 | 111 | $3,108 | $3,046 | 98.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 33 | 33 | $2,640 | $2,374 | 89.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 76 | 76 | $1,976 | $1,660 | 84.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 63 | 105 | $2,940 | $918.48 | 31.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 26 | 45 | $1,125 | $729.90 | 64.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 18 | 19 | $1,349 | $687.60 | 51.0% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 16 | 16 | $440.00 | $431.20 | 98.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 63 | 85 | $1,020 | $187.00 | 18.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 11 | $220.00 | $178.20 | 81.0% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 12 | 12 | $72.00 | $51.48 | 71.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 55 | 92 | $495.00 | $7.88 | 1.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 507 | 1,370 | $171,250 | $103,604 | 60.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 388 | 388 | $48,500 | $47,019 | 96.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 178 | 259 | $23,310 | $14,605 | 62.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 47 | 47 | $7,990 | $7,371 | 92.3% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 37 | 42 | $8,820 | $6,276 | 71.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 28 | 32 | $8,800 | $6,235 | 70.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 31 | 31 | $4,960 | $4,861 | 98.0% |
About Dr. Jennifer Nelson, DO
Dr. Jennifer Nelson, DO is a Family Medicine healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336222512.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Nelson, DO has received a total of $9,999 in payments from pharmaceutical and medical device companies, with $1,846 received in 2024. These payments were reported across 742 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($9,959).
As a Medicare-enrolled provider, Nelson has provided services to 7,156 Medicare beneficiaries, totaling 10,732 services with total Medicare billing of $757,807. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Paducah, KY
- Active Since 10/23/2006
- Last Updated 09/04/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1336222512
Products in Payments
- JARDIANCE (Drug) $520.57
- Ozempic (Drug) $448.24
- XIFAXAN (Drug) $418.08
- FARXIGA (Drug) $402.57
- TROKENDI XR (Drug) $366.48
- VRAYLAR (Drug) $346.64
- UBRELVY (Drug) $304.24
- Victoza (Drug) $300.88
- MOUNJARO (Drug) $292.05
- Rybelsus (Drug) $237.22
- EMGALITY (Drug) $236.34
- REXULTI (Drug) $235.85
- TRULICITY (Drug) $218.81
- NURTEC ODT (Drug) $208.58
- ENTRESTO (Drug) $204.09
- Prolia (Biological) $195.90
- QULIPTA (Drug) $193.04
- TRINTELLIX (Drug) $181.31
- VYVANSE (Drug) $172.65
- Saxenda (Drug) $169.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Paducah
James Turnbo, M.d. Psc, M.D. PSC
Family Medicine — Payments: $102,611
Dr. James Eickholz, Md, MD
Family Medicine — Payments: $15,716
Marissa Stewart-Jaynes, Md, MD
Family Medicine — Payments: $11,353
Kyle Parish, Md, MD
Family Medicine — Payments: $9,910
Isaac Mittendorf, Md, MD
Family Medicine — Payments: $9,065
Mr. Kenneth Cook, Md, MD
Family Medicine — Payments: $7,920